Calamos Advisors’s Transmedics TMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14,155
| Closed | -$2.22M | – | 918 |
|
|
2024
Q3 | $2.22M | Sell |
14,155
-3,692
| -21% | -$580K | 0.01% | 575 |
|
|
2024
Q2 | $2.69M | Buy |
17,847
+9,047
| +103% | +$1.36M | 0.01% | 541 |
|
|
2024
Q1 | $651K | Buy |
+8,800
| New | +$651K | ﹤0.01% | 662 |
|
|
2023
Q3 | – | Sell |
-61,343
| Closed | -$5.15M | – | 960 |
|
|
2023
Q2 | $5.15M | Buy |
61,343
+4,639
| +8% | +$390K | 0.03% | 549 |
|
|
2023
Q1 | $4.29M | Sell |
56,704
-3,528
| -6% | -$267K | 0.02% | 644 |
|
|
2022
Q4 | $3.72M | Sell |
60,232
-5,498
| -8% | -$339K | 0.02% | 698 |
|
|
2022
Q3 | $2.74M | Buy |
+65,730
| New | +$2.74M | 0.01% | 787 |
|
|
2021
Q4 | – | Sell |
-118,141
| Closed | -$3.91M | – | 1131 |
|
|
2021
Q3 | $3.91M | Buy |
+118,141
| New | +$3.91M | 0.02% | 640 |
|